ArticleCHEST pulmonary2025
Understanding Inpatient Sleep Studies for Sleep-Disordered Breathing: A Retrospective Population-Based Study of Health Administrative Databases.
Article in CHEST pulmonary, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The utility of inpatient vs outpatient polysomnography (PSG) for individuals with sleep-disordered breathing is unclear. Research Question: How do patient characteristics and sleep medicine care patterns differ between individuals undergoing inpatient vs outpatient PSG? Study Design and Methods: We conducted a retrospective population-based health administrative database study on all adult Ontarians (Canada) hospitalized and/or who underwent PSG between 2012 and 2018. We compared individuals who underwent PSG: (1) during hospitalization (inpatient PSG), (2) within the first month after discharge (delayed PSG), and (3) were not hospitalized in the last year (outpatient PSG). Outcomes included the following: baseline characteristics at the time of PSG, outpatient follow-up rates, and positive airway pressure claims in the year after PSG. Results: We identified 748 individuals in the inpatient group, 9,310 in the delayed group, and 730,967 in the outpatient PSG group. Compared with delayed or outpatient PSG groups, in unadjusted analyses, individuals in the inpatient PSG group were more likely to be older, previously assessed for sleep-disordered breathing, reside in a low-income neighborhood, and have greater comorbidity burden (standardized differences > 0.10). In adjusted analysis, individuals in the inpatient PSG group were less likely to be seen in the sleep clinic within the first year after PSG than the delayed or outpatient PSG group (hazard ratio [HR], 0.79; 95% CI, 0.71-0.87), with no difference between the delayed and outpatient PSG groups (HR, 1.00; 95% CI, 0.98-1.03). Compared with the delayed or outpatient PSG group, those in the inpatient PSG group were 21% (HR vs delayed group, 0.79; 95% CI, 0.67-0.94) to 53% (HR vs outpatient group, 0.47; 95% CI 0.27-0.82) less likely to initiate CPAP or auto-titrating positive airway pressure, and 2 to 10 times more likely to initiate bilevel positive airway pressure (HR vs outpatient group, 10.03; 95% CI, 7.30-13.77). Interpretation: Our results indicate that individuals undergoing inpatient PSG represent a unique smaller subgroup with greater comorbidity and social disadvantage, whereas the delayed PSG group may represent an optimal model of care, informing directions for future prospective studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.